Janiczek Wealth Management LLC Buys 2,668 Shares of Premier, Inc. (NASDAQ:PINC)

Janiczek Wealth Management LLC grew its position in Premier, Inc. (NASDAQ:PINC) by 105.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,201 shares of the company’s stock after acquiring an additional 2,668 shares during the quarter. Janiczek Wealth Management LLC’s holdings in Premier were worth $115,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in Premier by 12.9% during the 3rd quarter. Vanguard Group Inc. now owns 14,013,386 shares of the company’s stock valued at $301,288,000 after acquiring an additional 1,597,067 shares during the period. Bank of Nova Scotia raised its stake in shares of Premier by 711.0% in the fourth quarter. Bank of Nova Scotia now owns 163,006 shares of the company’s stock worth $3,645,000 after purchasing an additional 142,907 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Premier by 10.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,413,931 shares of the company’s stock worth $31,615,000 after purchasing an additional 129,813 shares during the last quarter. Carolina Wealth Advisors LLC grew its holdings in Premier by 79.5% during the first quarter. Carolina Wealth Advisors LLC now owns 264,696 shares of the company’s stock worth $5,850,000 after acquiring an additional 117,242 shares during the period. Finally, Quadrant Capital Group LLC grew its holdings in Premier by 41.9% during the fourth quarter. Quadrant Capital Group LLC now owns 7,452 shares of the company’s stock worth $167,000 after acquiring an additional 2,200 shares during the period. Institutional investors own 74.41% of the company’s stock.

Premier Trading Down 1.2 %

Shares of PINC stock traded down $0.22 during mid-day trading on Thursday, hitting $18.28. 493,073 shares of the company’s stock were exchanged, compared to its average volume of 1,639,971. Premier, Inc. has a fifty-two week low of $17.95 and a fifty-two week high of $28.30. The stock has a 50-day simple moving average of $19.49 and a two-hundred day simple moving average of $20.91. The company has a quick ratio of 0.82, a current ratio of 0.93 and a debt-to-equity ratio of 0.01. The stock has a market cap of $1.92 billion, a price-to-earnings ratio of 28.91, a PEG ratio of 6.21 and a beta of 0.44.

Premier (NASDAQ:PINC) last issued its earnings results on Tuesday, May 7th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.07. The business had revenue of $342.60 million for the quarter, compared to analyst estimates of $312.92 million. Premier had a return on equity of 11.71% and a net margin of 6.01%. Equities analysts expect that Premier, Inc. will post 1.96 EPS for the current fiscal year.

Premier Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Saturday, June 15th. Investors of record on Saturday, June 1st were given a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 4.60%. The ex-dividend date of this dividend was Friday, May 31st. Premier’s dividend payout ratio (DPR) is currently 131.25%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on PINC shares. StockNews.com raised Premier from a “hold” rating to a “buy” rating in a research note on Thursday, May 9th. Piper Sandler cut their price objective on Premier from $24.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, May 8th. Canaccord Genuity Group cut Premier from a “buy” rating to a “hold” rating and lowered their target price for the stock from $27.00 to $21.00 in a research note on Wednesday, May 8th. Robert W. Baird lowered their target price on Premier from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. Finally, JPMorgan Chase & Co. lowered their price objective on Premier from $23.00 to $21.00 and set a “neutral” rating for the company in a research report on Tuesday, May 28th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $23.50.

Insider Buying and Selling

In related news, General Counsel David L. Klatsky sold 13,339 shares of the stock in a transaction on Monday, June 10th. The stock was sold at an average price of $18.55, for a total value of $247,438.45. Following the transaction, the general counsel now directly owns 92,001 shares of the company’s stock, valued at approximately $1,706,618.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Premier news, General Counsel David L. Klatsky sold 13,339 shares of the firm’s stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $18.55, for a total value of $247,438.45. Following the transaction, the general counsel now directly owns 92,001 shares of the company’s stock, valued at $1,706,618.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Helen M. Boudreau sold 6,629 shares of the firm’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $19.85, for a total value of $131,585.65. Following the completion of the transaction, the director now directly owns 16,067 shares in the company, valued at $318,929.95. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 69,075 shares of company stock valued at $1,328,050. 0.85% of the stock is currently owned by company insiders.

About Premier

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.